NemaLife's mission is to accelerate and de-risk R&D for companies in the food, nutraceutical, microbiome and pharma industries. In these industries, performing human-relevant high throughput biology and doing so with efficiency and speed has been a mutually exclusive affair. NemaLife has solved this major challenge by developing an AI-assisted microfluidics-based in vivo platform based on the microscopic worm C. elegans that has strong relevance for human biology. This 3R-compliant cruelty-free technology capable of testing a variety of compounds and their combinations is an alternative to expensive and time-consuming mouse models. We work with companies as their R&D partner, accelerating the value-chain from early-phase discovery to assessment of product potency and health claims. Our interdisciplinary team of engineers and biologists work with you to achieve your R&D objectives as well as co-create assets by developing custom biological readouts and new tech platforms. We have significant pre-clinical expertise in human wellness areas related to gut health, brain health, muscle health, metabolic health, cognitive health and healthy aging. We would be happy to share more details in a 15 min call.